Show simple item record

Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

dc.contributor.authorMalik, Sara
dc.contributor.authorEŞKAZAN, Ahmet Emre
dc.contributor.authorHassan, Shahzeb
dc.date.accessioned2021-12-10T12:11:48Z
dc.date.available2021-12-10T12:11:48Z
dc.identifier.citationMalik S., Hassan S., EŞKAZAN A. E. , "Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia", EXPERT REVIEW OF HEMATOLOGY, 2021
dc.identifier.issn1747-4086
dc.identifier.otherav_adeb33a4-c7ad-40b4-8cdd-140e0c38ce7e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/173412
dc.identifier.urihttps://doi.org/10.1080/17474086.2021.1990034
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectHematology
dc.subjectHealth Sciences
dc.titleNovel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
dc.typeMakale
dc.relation.journalEXPERT REVIEW OF HEMATOLOGY
dc.contributor.departmentNorthwestern State University Of Louisiana , ,
dc.contributor.firstauthorID2757896


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record